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Abstract: 
Introduction: Primary ciliary dyskinesia (PCD; MIM 244400) is a heterogeneous autosomal recessive genetic disorder 
associated with infertility due to impaired sperm motility in men. We describe two such cases and give a literature review 
on the genetic background and reproductive outcome.   
Materials and methods: Two primary infertile couples were referred to our clinic. Native semen, analyzed according to 
the WHO manual (2010), showed that male partners have completely immotile sperm with a negative pentoxifylline test. 
Sample vitality was compared according to different semen preparation methods (gradient density and washing method 
only). Genetic testing was done by Whole Exome next-generation Sequencing (WES) analysis. For the IVF/ICSI 
procedure, semen was prepared using the gradient density method, and prior to the ICSI procedure itself, a hypo-osmotic 
swelling test (HOST) was done.  
Results: Semen analysis showed oligoasthenozoospermia in Patient 1 and oligoasthenoteratozoospermia in Patient 2. 
Blood draw for hormones and karyotype showed no irregularities in either case. Patient 1 was previously diagnosed with 
PCD, while Patient 2 was not. Parallel vitality testing did not show any differences between the two semen preparation 
methods in either of the two cases. Genetic testing in Patient 2 showed a pathogenic apparently homozygous 
CCDC40:c.2440C>T variant in exon 14 of the CCDC40 gene (MIM 613799). Fertilization rate after HOST/ICSI in both 
patients was 100%, and the final outcome for both patients was the birth of a healthy child. 
Conclusion: Although PCD has diverse etiology, assisted reproduction techniques such as HOST give these couples a 
good chance for parenthood. Advances in testing and strict adherence to advised procedures are to be credited for such 
outcome improvement. Additionally, our recommendation for PCD patients and patients with immotile sperm is to do 
genetic testing and counselling prior to the IVF/ICSI procedure. 
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Primary ciliary dyskinesia (PCD; MIM 244400) is 
heterogeneous autosomal recessive genetic disorder 
involving permanent ubiquitous structural and/or 
functional ciliary abnormalities. If PCD is accompanied 
with dextrocardia/situs inversus, this condition is then 
called Kartagener syndrome.1  
Cilia have a complex structure. The central part of a 
cilium is its cytoskeletal structure called the axoneme. It 
consists of 9 outer microtubule doublets, which are 
accompanied with 2 additional central singlet 
microtubules2 in case of motile cilia, such as respiratory 
and fallopian tube cilia and sperm flagella. Those 
microtubules are associated with many proteins 
responsible for cilia movement. Inner (IDA) and outer 
(ODA) dynein arms are motor complexes required for 
providing the motor force for structure movement. The 
radial spokes provide physical support by building 
structures between peripheral microtubules and the 
central pair. They are also responsible for governing 
ciliary beat and waveform by transducing signals 
between dynein arms and the center of the axoneme. 
Nexin-dynein regulatory complexes regulate and 
orchestrate dynein activity by generating coordinated 
microtubule sliding in motile axonemes.3 
More than 30 genes have been implicated in the PCD 
condition (Chodhari et al, 2004), and most of them 
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encode for axonemal dyneins (DNAI1, DNAI2, DNAH5, 
DNAH11, DNAAF2 and LRRC50).4 
Gene mutations can be reflected in ultrastructure 
changes detectable by transmission electron microscopy 
(TEM). Around 90% of individuals with PCD have 
ultrastructural defects affecting ODA and/or IDA 
protein(s).5 
Recognized ODA defects have been associated with the 
following genes: DNAH5, DNAI1, DNAI2, DNAL1, 
NME8, CCDC114, CCDC151, ARMC4 and TTC25. In 
38% of the cases, mutations are located on DNAI1 and 
DNAH5.5  
ODA+IDA defects are known to occur due to mutations 
in multiple genes that encode for proteins needed for 
pre-assembly of ciliary axonemes: DNAAF1, DNAAF2, 
DNAAF3, LRRC6, C21ORF59, HEART2, ZMYND10, 
DYX1C1, SPAG1, CCDC103 and PIH1D3.6 
IDA defects are associated with MTD (microtubule 
disorganization) in less than 50% of cases. These defects 
are reflected in ciliar structural changes such as missing 
inner dynein arms. Mutation in CCDC39 and CCDC40 
is the major cause of PCD with axonemal 
disorganization and absent inner dynein arms.7, 8 
Although gene mutations have a strong impact on sperm 
motility, they are not always visible as ultrastructure 
changes detectable with TEM. This is the case with 
mutations in DNAH11 and HYDIN.6 
Except for the abovementioned gene mutations which 
have an impact on ODA and IDA, there are also 
mutations in genes that encode for central microtubule 
structures (RSPH4A and RSPH9), nexin links and 
dynein regulatory complex (CDCC164 and GAS8), 
thioredoxin (TXNDC3), and X-linked gene (RPGR) 
associated with retinis pigmentosa.9  
Symptoms of absent cilia motility are chronic sinus 
infections, chronic middle ear infections and hearing 
loss, recurrent respiratory infections and infertility. 
Many PCD patients are still undiagnosed or 
misdiagnosed, and only a limited number of centers 
have extensive experience in the diagnosis and 
management of PCD. Therefore, the European 
Respiratory Society brought consensus 
recommendations for diagnosis, monitoring and 
management of PCD.10 
The main consequence of impaired sperm motility in 
male PCD patients is infertility.11 The aim of this paper 
was to present literature data on reproductive outcomes 
following intracytoplasmic sperm injection (ICSI) with 
completely immotile ejaculated sperm in patients with 
PCD and to improve the understanding of the genetic 
background of this condition. 
 
 
MATERIAL AND METHODS 
We treated two couples with primary infertility caused 
by male partners with completely immotile sperm. 
Clinical and biological data of the two reported PCD 




Native semen concentration, motility and morphology 
parameters were analyzed according to the WHO 
manual (2010).12 Additionally, both samples were tested 
with pentoxifylline in order to enhance motility, but test 
results were negative. 
 
 
Vitality testing after different semen preparation 
methods 
Semen was aliquoted and processed using the gradient 
density method and the sperm washing method. 
 
 
Table 1. Clinical and biological data on two reported PCD patients 
  Case 1 Case 2 
Age of couple 30 (female) and 32 (male) 34 (female) and 32 (male) 
Semen analysis 
volume: 2.5ml                                       
concentration: 14x106/ml                                 
vitality 82% and morphology 11.5% 
volume: 1ml                                             
concentration: 1.5x106/ml                                       
vitality 40.5% and morphology 1.5% 
Hormonal status (male) FSH 3.6 IU/l, LH 5.8 IU/l, testosterone 4.7 ug/l FSH 4.7 IU/l, LH 6.9 IU/l, testosterone 4.5 ug/l 
PCD recognised previously No Yes 
Karyotype Normal in both partners Normal in both partners 
Genetic testing No 
A pathogenic apparently homozygous 
CCDC40:c.2440C>T variant was identified in exon 
14 of the CCDC40 gene (ref seq NM_017950.3)  
Vitality % gradient density method  
vs. sperm wash method 
71% vs 68% 38% vs 35% 
Previous IVF attempts No Yes (semen donation program in another clinic) 
Ovarian stimulation  Clomiphene citrate/HMG/hCG rFSH/GnRHa/hCG 
Fertilisation rate 2 embryos of 2 MII oocytes 9 embryos of 9 MII oocytes (1 zygote was 3PN) 
Embryo transfer Fresh cycle: 2 embryos on day 3   
Fresh cycle: „freeze all“  
FET: 1 embryo 
IVF outcome 
live birth at 38+2 weeks,                                 
female: length 47cm/weight 2440g 
live birth at 40 weeks,                                           
male: length 51cm/weight 3700g 
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Gradient density method: the ejaculate was centrifuged 
at 80% / 40% density gradient (PureCeption 80% Lower 
Phase Gradient / PureCeption 40% Upper Phase 
Gradient, SAGE In-vitro Fertilization, Inc., 
CooperSurgical, USA) for  15 minutes at 300g, then 
washed twice with a washing medium (Quinns 
Advantage® Sperm Washing Medium, SAGE In-vitro 
Fertilization, Inc., CooperSurgical, USA) for 7 minutes 
at 600g. The obtained sperm pellet was resuspended in 
0.5 ml of sperm washing media.  
Washing method: the ejaculate was centrifuged in a 
sperm wash medium for 10 minutes at 600g twice. The 
obtained sperm pellet was resuspended in 0.5 ml of 
sperm washing media. 
After the semen samples were processed, they were 
analyzed using the Eosin vitality test (Figure 1) 




Figure 1. Vitality distinguish by eosin staining 
(vital sperm were transparent (*); non-vital sperm were dyed red) 
 
Genetic testing  
Patient genomic DNA (gDNA) was extracted from 
peripheral blood. Whole exome sequencing (WES) was 
performed in the genetic testing service facility using 




Gametes and embryos were cultivated in incubators 
adjusted to 6% CO2 and 5% O2. All culture media were 
prepared a day earlier; a culture was prepared in drops 
of oil-covered medium. The equipment used in the 
procedures was as follows: disposable plastic material 
for the IVF procedures (Nunc Art IVF Product Line, 
Thermo Scientific™, USA), 17G needles (Cook 
Medical, William A. Cook Australia Pity.Ltd., 
Australia), micromanipulation pipettes (Research 
Instruments Ltd, UK) and catheters for embryo transfer 
(ET) (Embryo Transfer Catheter, Cook Medical, USA).  
The ejaculate was prepared using the gradient density 
method as already described above. The obtained sperm 
pellet was resuspended in 0.2 ml of fertilization medium 
(Quinns Advantage® Fertilization Medium, SAGE In-
vitro Fertilization Inc., CooperSurgical, USA) and 
placed into an incubator while waiting for insemination.  
After retrieval from follicular fluid, oocytes were 
washed in the fertilization medium, granulosa cells were 
mechanically removed up to corona radiata, after which 
oocytes were placed into a Petri dish with 40 µl culture 
medium droplets covered with oil (Oil for Tissue 
Culture, SAGE In-vitro Fertilization, Inc., 
CooperSurgical, USA).  
After a 3-hour period of pre-incubation, the ICSI 
procedure was performed. In the Petri dish with the oil-
covered stabilized fertilization medium, oocytes were 
first enzymatically denuded (ICSI Cumulase, Origio, 
Denmark), washed through a series of 40 µl drops and 
placed into 10 µl drops for the ICSI procedure. Sperm 
was placed into one drop of 40 µl fertilization medium. 
From a semen pool, the sperm with best morphologic 
features were chosen and placed into a hypoosmotic 
solution (HOS) prepared according to Sallam et al.13 
Sperm were tested one by one. After the appearance of 
tail loop (Figure 2), a characteristic trait of sperm 
vitality, the sperm was transferred into the washing 
medium as soon as possible to recover. Following that, 
the sperm was placed into polyvinylpyrrolidone (PVP 
7%, SAGE In-vitro Fertilization, Inc., CooperSurgical, 
USA) and the tail was mechanically drilled prior to the 
ICSI procedure itself. After 20 hours, fertilization was 
checked, culture medium was changed, and the culture 
continued in a sequential medium (Quinns Advantage® 
Cleavage Medium, SAGE In-vitro Fertilization, Inc., 
CooperSurgical, USA). After 48 hours another quality 
grading of embryonic development was done.  
For extended cultivation, the medium (Quinns 
Advantage® Blastocyst Medium, SAGE In-vitro 
Fertilization, Inc., CooperSurgical, USA) was changed 
on day 3. Embryonic development was checked and 




Figure 2. Hypo osmotic swelling test 




On day 5, blastocysts of sufficient grading quality, 
according to Istanbul Consensus (2011), were vitrified 
(Vitrification Media, Kitazato Corp., Japan) using an 
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open system carrier (Cryotop, Kitazato Corp., Japan) 
and cryopreserved in liquid nitrogen, as per the 
manufacturer’s instructions.  
 
Thawing  
Thawing of embryos was performed using thawing 
solutions (Vitrification Media, Kitazato Corp., Japan), 
as per the manufacturer’s instructions. After thawing, 
embryos were cultured in droplets of blastocyst medium 
covered with oil, for 2 hours prior to ET. 
 
Embryo transfer 
Embryos were put in one well dish with the preincubated 





Clinical data and IVF/ICSI outcome of two PCD 
patients are presented in Table 1. 
Peripheral blood hormone values for both male patients 
were normal. Karyotyping of peripheral blood 
lymphocytes has shown a normal male karyotype for 
both patients. Both patients have suffered from chronic 
sinus infections, recurrent respiratory infections and 
infertility, but only in Patient 2 were the symptoms 
recognized as PCD in childhood. This patient’s genetic 
testing has shown that he carries the homozygous 
CCDC40:c.2440C>T variant identified in exon 14 of the 
CCDC40 gene (ref seq NM_017950.3).  
 
 
Vitality test according to semen preparation method 
A comparison between the two different methods of 
sperm preparation suggested that there was no 
difference in vital sperm percentage after sperm 
preparation with the gradient density or the sperm 
washing method. 
 
IVF procedure and outcome 
After the ICSI procedure, fertilization rate in both cases 
was 100%. In Case 2, one zygote was 3PN. 
In Case 1, embryo transfer was performed in a fresh 
cycle on day 3. One embryo had eight cells, and the 




Figure 3. Hypo osmotic swelling test 
(ET: transferred embryos) 
 
 
In Case 2, there were eight embryos on day 3 (Figure 
4A). All embryos were frozen in a fresh cycle, and three 
blastocysts were cryopreserved, each separately, on day 
5 (Figure 4B). 
In Case 2, pregnancy was achieved from the frozen/thaw 




Literature data (Table 2) on PCD patients with 
exclusively immotile sperm have shown good 
reproductive prognosis  after IVF/ICSI procedures  with  
 
 
   Figure 4. Case 2 embryos on day 3 (A) and day 5 (B)  Cryopreserved embryos (K1, K2, K3) 
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Figure 5. Case 2 embryo from frozen/thaw cycle 
(ET: embryo transferred) 
 
 
ejaculated sperm: fertilization rate was 55%, pregnancy 
rate 45% and live birth rate 36% [14]. When using 
HOST, as we described previously, our fertilization and 
success rate were even higher. 
The CCDC40 (MIM 613799) gene, located on 
chromosome 17q25, encodes a protein that is necessary 
for motile cilia function. In their study, Becker-Heck et 
al8 showed using TEM analysis that PCD patients with 
mutated CCDC40 have cilia with a variety of defects in 
several axonemal structures. Some of them have absent 
or eccentric central pairs, displacement of outer doublets 
and reductions in the mean number of inner dynein arms. 
It is interesting that outer dynein arms suffered no 
malformations. Following that, the authors concluded 
that CCDC40 might have several functions, such as 
physical interaction with the other axonemal 
components, serving as a part of the axoneme structural 
scaffold, and possibly having a role as dynein regulatory 
complex component. This gene has 20 exons.8 
Mutations in this gene occur most frequently in exons 3 
and 10, but they are also described in most of the other 
exons and even some introns. A person might have 
homozygous mutation or compound heterozygous 
mutations, depending on the case.7, 25 
Our Patient 2 male patient has been diagnosed with PCD 
type 15 (MIM 613808), which means he has a mutation 
in the CCDC40 gene present in exon 14 in the 
homozygous form (CCDC40:c.2440C>T variant). This 
mutation caused protein truncation because Arginine 
was replaced with a premature stop codon. There are two 
citations in literature describing this specific mutation. 
The identical mutation was described in a patient with 
North European origin.7 The other one was described in 
a Yugoslavian patient, but in combination with another 




Although PCD has diverse etiology, assisted 
reproduction techniques in combination with HOST 
give these couples a good chance for parenthood. 
Advances in testing and strict adherence to procedures 
advised are to be credited for such outcome 
improvement. Additionally, our recommendation for 
PCD patients and patients with immotile sperm is to do 








IVF outcome Fertilisation rate (F); 
live birth (LB) 
Reference 
Patient 1:  sperm concentration 75x106/mL 
Patient 2:  sperm concentration 210x106/mL 
 
random sperm pick 
F: 66%; LB: twins  
F: 50%; LB: singleton 
[15] 
    Patient 1:   sperm concentration 58x106/mL random sperm pick no fertilization  [16] 
    Patient 1:  severe oligozoospermia HOST no fertilization 
[17]  Patient 2:  normal sperm count; normal 1) 50% ejaculated with HOST F: 44%; 
                 morphology; vitality 63% 2) 50% TESE with HOST F: 55%; LB: singleton (from TESE) 
    Patient 1:  sperm concentration 1,4x106/mL; 
                 morphology 3%  
HOST F: 66%; LB: singleton [18] 
    Multiple cases with total immotility 
(not exclusively PCD) 
1) random sperm pick 
2) tail laser shot 
take home baby rate 16.7%  
take home baby rate 28%  
[19] 
    Patient 1:  sperm concentration 24-40x106/mL; 
                 morphology 4%; vitality 40%  
HOST F: 83%; LB: twins [20] 
    Patient 1:  sperm concentration 0,9x106/mL; 
                 vitality 54%  
pentoxifylline-activated sperm F: 58%; LB: singleton [21] 
    Patient 1:  sperm concentration 43x106/mL  HOST F: 50%; LB: twins [22] 
    Patient 1:  sperm concentration 1,8 x106/mL; 
                 vitality 32%  
1) HOST 
2) HOST with oocyte activation 
no fertilisation 
F: 66%; LB: twins 
[23] 
    Patient 1:  sperm concentration 5x106/mL; 
                 morphology 0%; vitality 54%  
laser assisted viability assessment 
(LAVA) 
F: 45%; LB: triplets [24] 
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